Summary of Study ST001924
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001214. The data can be accessed directly via it's Project DOI: 10.21228/M8SH7V This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
Study ID | ST001924 |
Study Title | Urine-Based Metabolomics and Machine Learning Reveals Metabolites Associated with Renal Cell Carcinoma Progression NMR (part-I) |
Study Summary | Every year, hundreds of thousands of cases of renal carcinoma (RCC) are reported worldwide. Accurate staging of the disease is important for treatment and prognosis purposes; however, contemporary methods such as computerized tomography (CT) and biopsies are expensive and prone to sampling errors, respectively. As such, a non-invasive diagnostic assay for staging would be beneficial. This study aims to investigate urine metabolites as potential biomarkers to stage RCC. In the study, we identified a panel of such urine metabolites with machine learning techniques. |
Institute | University of Georgia |
Department | Biochemistry and Molecular Biology |
Laboratory | Edison Lab/Fernandez Lab |
Last Name | Bifarin |
First Name | Olatomiwa |
Address | 315 Riverbend Rd, Athens, GA 30602 |
olatomiwa.bifarin25@uga.edu | |
Phone | (706) 542-4401 Lab: 1045 |
Submit Date | 2021-08-16 |
Raw Data Available | Yes |
Raw Data File Type(s) | fid |
Analysis Type Detail | NMR |
Release Date | 2021-10-18 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Treatment:
Treatment ID: | TR002014 |
Treatment Summary: | There were no treatments in the study, urine samples of renal cell carcinoma patients were collected. |